文献
J-GLOBAL ID:201402243290042552
整理番号:14A0041723
IPI-145によるPI3K-δおよびPI3K-γの阻害は,自己免疫疾患および炎症性疾患モデルにおいて免疫応答を抑止し,活性を抑制する
PI3K-δ and PI3K-γ inhibition by IPI-145 abrogates immune responses and suppresses activity in autoimmune and inflammatory disease models
著者 (28件):
WINKLER David G.
(Infinity Pharmaceuticals, Inc., MA, USA)
,
FAIA Kerrie L.
(Infinity Pharmaceuticals, Inc., MA, USA)
,
DINITTO Jonathan P.
(Infinity Pharmaceuticals, Inc., MA, USA)
,
ALI Janid A.
(Infinity Pharmaceuticals, Inc., MA, USA)
,
WHITE Kerry F.
(Infinity Pharmaceuticals, Inc., MA, USA)
,
BROPHY Erin E.
(Infinity Pharmaceuticals, Inc., MA, USA)
,
PINK Melissa M.
(Infinity Pharmaceuticals, Inc., MA, USA)
,
PROCTOR Jennifer L.
(Infinity Pharmaceuticals, Inc., MA, USA)
,
LUSSIER Jennifer
(Infinity Pharmaceuticals, Inc., MA, USA)
,
MARTIN Christian M.
(Infinity Pharmaceuticals, Inc., MA, USA)
,
HOYT Jennifer G.
(Infinity Pharmaceuticals, Inc., MA, USA)
,
TILLOTSON Bonnie
(Infinity Pharmaceuticals, Inc., MA, USA)
,
MURPHY Erin L.
(Infinity Pharmaceuticals, Inc., MA, USA)
,
LIM Alice R.
(Infinity Pharmaceuticals, Inc., MA, USA)
,
THOMAS Brian D.
(Infinity Pharmaceuticals, Inc., MA, USA)
,
MACDOUGALL John R.
(Infinity Pharmaceuticals, Inc., MA, USA)
,
FRITZ Christian C.
(Infinity Pharmaceuticals, Inc., MA, USA)
,
DUNBAR Joi L.
(Infinity Pharmaceuticals, Inc., MA, USA)
,
PORTER James R.
(Infinity Pharmaceuticals, Inc., MA, USA)
,
PALOMBELLA Vito J.
(Infinity Pharmaceuticals, Inc., MA, USA)
,
CHANGELIAN Paul S.
(Infinity Pharmaceuticals, Inc., MA, USA)
,
KUTOK Jeffery L.
(Infinity Pharmaceuticals, Inc., MA, USA)
,
REN Pingda
(Intellikine, Inc., CA, USA)
,
LIU Yi
(Intellikine, Inc., CA, USA)
,
LI Lian-Sheng
(Intellikine, Inc., CA, USA)
,
JESSEN Katti A.
(Intellikine, Inc., CA, USA)
,
ROMMEL Christian
(Intellikine, Inc., CA, USA)
,
ROMMEL Christian
(Amgen Inc., CA, USA)
資料名:
Chemistry and Biology
(Chemistry and Biology)
巻:
20
号:
11
ページ:
1364-1374
発行年:
2013年
JST資料番号:
A1202A
ISSN:
1074-5521
資料種別:
逐次刊行物 (A)
発行国:
オランダ (NLD)
言語:
英語 (EN)